Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02549508 · ClinicalTrials.gov registry record · NA
Comparison Study Using APAP With and Without SensAwake in Patients With OSA and PTSD
A NA study, sponsored by Fisher and Paykel Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT02549508 is a NA study that has completed, run by Fisher and Paykel Healthcare. The registered enrollment target is 85 participants.
The verdict
NCT02549508, a NA study, has completed, sponsored by Fisher and Paykel Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
The purpose of this research is to examine the application of AutoCPAP with and without SensAwake in subjects with OSA and Post-Traumatic Stress Disorder (PTSD), and evaluate whether patients achieve better sleep quality and compliance with SensAwake, compared to the same treatment without SensAwake.
Interventions
- DEVICE AutoCPAP with SensAwake On
- DEVICE AutoCPAP with SensAwake Off
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2015-10 |
| Est. Completion | 2018-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02549508
The ClinicalTrials.gov registry entry for NCT02549508 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fisher and Paykel Healthcare, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AutoCPAP with SensAwake On is the first listed.
NCT02549508 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02549508 about?
NCT02549508 is a clinical study titled "Comparison Study Using APAP With and Without SensAwake in Patients With OSA and PTSD". The purpose of this research is to examine the application of AutoCPAP with and without SensAwake in subjects with OSA and Post-Traumatic Stress Disorder (PTSD), and evaluate whether patients achieve better sleep quality and compliance with SensAwake, compared to the same treatment without SensAwake...
What is the current status of trial NCT02549508?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2015-10. Estimated completion is 2018-05.
What interventions are being tested in trial NCT02549508?
The interventions under investigation include: AutoCPAP with SensAwake On (DEVICE), AutoCPAP with SensAwake Off (DEVICE).
Who is sponsoring clinical trial NCT02549508?
This trial is sponsored by Fisher and Paykel Healthcare, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.